ARTICLE | Finance
Gilead Sciences Inc. (GILD)
February 26, 2001 8:00 AM UTC
Gilead(GILD) was down $0.312 to $34.563 on the week after announcing that its Tenofovir nucleotide analog met the primary end point of a significant reduction in HIV RNA compared to placebo after 24...